Adverse Effects
![]()
All Items
-
DOI: 10.12890/2026_007381
Combined calcium channel blocker and angiotensin-converting enzyme inhibitor overdose
DOI: 10.12890/2026_007398
Iatrogenic hypercalcemia in a patient with type 2 diabetes and chronic kidney disease
DOI: 10.12890/2026_007356
DOI: 10.12890/2026_007261
DOI: 10.12890/2026_007262
Roxadustat-associated cholestatic jaundice in haemodialysis patients with positive rechallenge
DOI: 10.12890/2026_006649
Semaglutide-induced ischemic colitis in a middle-aged female without vascular risk factors
DOI: 10.12890/2026_006801
DOI: 10.12890/2026_006759
DOI: 10.12890/2026_006500
DOI: 10.12890/2026_006544
Recurrent pleuropericarditis associated with mesalazine therapy masked by steroid use
DOI: 10.12890/2026_006178
Bleeding disorder, a newly recognized adverse event following sacubitril/valsartan therapy
DOI: 10.12890/2026_005605
DOI: 10.12890/2026_006046
One dose, one wall: isolated septal hypokinesia triggered by first doxorubicin exposure
DOI: 10.12890/2025_005913
The paradoxical pro-arrhythmic effect of ginseng: a case of atrial fibrillation in a healthy adult
DOI: 10.12890/2025_005852
Anabolic-androgenic steroid–induced pneumonitis and myocardial injury in a young bodybuilder